[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591965":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":30,"locations":37,"responsibleParty":55,"collaborators":26,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":26,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":26,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":26,"overallStatus":40,"whyStopped":26,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Wecare Probiotics Co., Ltd.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Probiotic Group","EXPERIMENTAL","Take Lactobacillus plantarum Lp90 at 30 billion CFU per day.",[13],"Dietary Supplement: Probiotic",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo Group","PLACEBO_COMPARATOR","Taking maltodextrin 3 g\u002Fday.",[19],"Dietary Supplement: Maltodextrin",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DIETARY_SUPPLEMENT","Probiotic","The trial period of this study is 3 months, and each patient will undergo 4 visits (in month 0, month 1, month 2, and month 3).",[9],null,{"type":22,"name":28,"description":24,"armGroupLabels":29,"otherNames":26},"Maltodextrin",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":35,"email":36},"Yingpeng Tian, Doctor","CONTACT","13671979116","＋86","tianyingpeng2021@163.com",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Fuwai Central-China Cardiovascular Hospital","RECRUITING","Zhengzhou","Henan","462000","China","CN",{"type":47,"coordinates":48},"Point",[49,50],113.64861,34.75778,{"lat":50,"lon":49},[53],{"name":54,"role":33,"phone":34,"phoneExt":26,"email":36},"Yingpeng Tian",{"type":56,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100591965","lactobacillus-plantarum-and-hormonal-regulation-in-obese-women-100591965",false,"NCT06987279","Lactobacillus Plantarum and Hormonal Regulation in Obese Women","Lactobacillus Plantarum Lp90 and Hormonal Regulation in Obese Women：A Randomized, Double-Blind, Placebo-Controlled Trial","Inclusion Criteria:\n\n1. Age: 18 to 40 years old, female, BMI ≥ 25 kg\u002Fm2.\n2. Be willing to receive follow-up during the intervention period.\n3. Be willing to provide two blood, urine and fecal samples during the intervention period.\n4. Be willing to take the compound probiotics by oneself every day during the intervention period.\n5. Have good hearing and be able to hear and understand all instructions during the intervention period.\n\n   \\-\n\nExclusion Criteria:\n\n1. Suffering from digestive system diseases, mainly gastrointestinal diseases (celiac disease, ulcerative colitis, Crohn's disease).\n2. Suffering from severe neurological disorders (epilepsy, stroke, severe head trauma, meningitis within the past 10 years, brain surgery, brain tumor, long-term coma - excluding general anesthesia).\n3. Have received\u002Fare currently receiving treatment for the following mental illnesses: alcohol\u002Fdrug\u002Fsubstance abuse dependence, schizophrenia, psychosis, bipolar disorder.\n4. Take medication for depression or low mood.\n5. Suffering from internal organ failure (such as heart, liver or kidney failure, etc.).\n6. Have received radiotherapy or chemotherapy in the past.\n7. Have received general anesthesia surgery\u002Fprocedures within the past three years, or plan to receive general anesthesia procedures\u002Fsurgeries within the next three months during this trial.\n8. Have suffered from hepatitis (hepatitis B, hepatitis C), HIV or syphilis in the past.\n\n   \\-",true,"FEMALE","18 Years","40 Years",{"count":69,"type":70},100,"ESTIMATED","INTERVENTIONAL",[73],"NA","To evaluate the regulatory effect of Lactobacillus plantans Lp90 formula on visceral fat metabolism and sex hormone balance in obese women.",[76],"Obesity, Women","2025-05-15",{"date":79,"type":80},"2025-05-23","ACTUAL",{"date":82,"type":70},"2025-06-10",{"date":84,"type":70},"2025-12-10",{"name":5,"class":6},1]